Manahil Mubeen, Aasiya Shahbaz Sakarwala, Arif Imdad Bijarani, Muhammad Taha Kamal
{"title":"Enhancing Heart Health: Expanding the Use of SGLT2 Inhibitors in Cardiovascular Disease","authors":"Manahil Mubeen, Aasiya Shahbaz Sakarwala, Arif Imdad Bijarani, Muhammad Taha Kamal","doi":"10.1002/med4.70014","DOIUrl":null,"url":null,"abstract":"<p>SGLT2 inhibitors offer multifaceted cardiovascular benefits, including improved cardiac metabolism, reduced preload and afterload, and decreased myocardial infarction risk. These effects are driven by renoprotection, anti-inflammatory properties, improved mitochondrial function, osmotic diuresis, and glycemic control. Together, these mechanisms support the role of SGLT2 inhibitors in reducing cardiovascular morbidity and mortality.\n <figure>\n <div><picture>\n <source></source></picture><p></p>\n </div>\n </figure></p>","PeriodicalId":100913,"journal":{"name":"Medicine Advances","volume":"3 2","pages":"122-126"},"PeriodicalIF":0.0000,"publicationDate":"2025-06-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/med4.70014","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medicine Advances","FirstCategoryId":"1085","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/med4.70014","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 0
Abstract
SGLT2 inhibitors offer multifaceted cardiovascular benefits, including improved cardiac metabolism, reduced preload and afterload, and decreased myocardial infarction risk. These effects are driven by renoprotection, anti-inflammatory properties, improved mitochondrial function, osmotic diuresis, and glycemic control. Together, these mechanisms support the role of SGLT2 inhibitors in reducing cardiovascular morbidity and mortality.